Sunshine Biopharma Inc. (ticker: SBFM) is an NASDAQ-listed pharma company. DredgeCap's structured extraction of SBFM's SEC filings surfaces 20 active risk signals, including 19 late-filing signals, and 1 auditor-change signal. SBFM reported $8.09M in revenue and -$1.24M for the period ending 2026-03-31, with operating cash flow of -$2.07M. Cash and equivalents stood at $6.91M (down 14.9% year-over-year). Total assets of $27.93M exceed total liabilities of $6.41M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
SBFM Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Sunshine Biopharma Inc. (SBFM) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.